Cite
HARVARD Citation
Locatelli, F. et al. (2016). Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials. Advances in therapy. 33 (4), pp. 610-625. [Online].